Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

VEGF gene medicine incorporating DOTMA enters phase II testing

March 25, 1998

Spotlight on dual-action ACE/NEP inhibitors

March 25, 1998

Calcium channel blockers do not increase risk of cancer in patients with coronary artery disease

March 24, 1998

U. of Alberta researchers discover novel 1,4-dihydropyridine calcium channel modulators

March 20, 1998

Vitamin C prevents development of nitrate tolerance in CHF

March 20, 1998

Mochida describes PDE V inhibitors for pulmonary hypertension, ischemic heart disease

March 20, 1998

CytRx begins patient enrollment for Flocor phase III trial

March 19, 1998

LXR files IND for CP-Cardiosol

March 19, 1998

Selective iNOS inhibitor improves hepatic circulation and oxygen metabolism in sepsis

March 18, 1998

AII blocker prevents complications of hypertension in SHR

March 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...